[1]
2026. Development of Functionalized 1,2,4-Triazole Derivatives as Potential Aromatase Inhibitors in Breast Cancer: Research Article. Journal of Pharma Insights and Research. 4, 2 (Apr. 2026), 116–124. DOI:https://doi.org/10.69613/hmd42z94.